PEPFAR Announces New Partners and Investments in DREAMS

Filed under: HEALTH |


Department of State
Washington, DC
December 1, 2015

Johnson & Johnson, Gilead Sciences, and ViiV Healthcare Join the U.S President’s Emergency Plan for AIDS Relief to Reduce HIV Infections in Adolescent Girls and Young Women

The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and a number of private sector partners today announced new investments in the DREAMS partnership, including the new DREAMS Innovation Challenge Fund. PEPFAR is committing $80 million from within its existing FY 2015 budget for this Fund, and a number of new private sector partners, including Johnson & Johnson, Gilead Sciences, and ViiV Healthcare are joining and committing an additional $25 million to support of both the DREAMS Partnership and Innovation Challenge Fund. These commitments will infuse innovative thinking into reducing HIV infections in adolescent girls and young women, with a priority focus on building the capacity of young women’s organizations and funding grassroots work.
Johnson & Johnson joins DREAMS as an anchor partner, alongside PEPFAR, the Bill & Melinda Gates Foundation, and Girl Effect. Gilead Sciences and ViiV Healthcare bring their unique assets, resources and critical expertise to the DREAMS partnership, which was launched on World AIDS Day 2014. Today’s announcements represent a robust and rapid private sector response to PEPFAR’s call to action in issuing the Innovation Challenge at the United Nations General Assembly this September.

Every year, 380,000 adolescent girls and young women are infected with HIV—7,300 every week, more than 1,000 every day. Working with partner countries, civil society, and private sector partners, by the end of 2017 PEPFAR aims to achieve a 40 percent reduction in HIV infections among adolescent girls and young women within the hardest hit areas of 10 sub-Saharan Africa countries, thereby supporting them to be Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe.

U.S. Global AIDS Coordinator, Ambassador Deborah L. Birx stated, “No greater action is needed right now to end AIDS than empowering adolescent girls and young women. These new partners will bring innovative thinking and critical resources, which will prevent new infections and save lives.”

As part of its investment in DREAMS, Johnson & Johnson will provide its expertise in consumer insights, and will commit financial resources to programs focused on empowerment of adolescent girls, ensuring improved access to treatment and prevention options, and creating supporting communities. Gilead Sciences will enhance pre-exposure prophylaxis (PrEP) programs for young women. ViiV Healthcare will provide financial resources to community-based organizations to improve grassroots innovation and capacity-building.

“Our ultimate goal is to make HIV history, and we are proud to partner with PEPFAR’s DREAMS initiative,” said Alex Gorsky, Chairman and CEO, Johnson & Johnson. “We join the global community today in honoring those who have made a significant difference in fighting HIV/AIDS. But much remains to be done in the battle against HIV/AIDS, and we believe that collaborations such as these are the most effective way forward to reach our ultimate goal.”

Gregg Alton, Executive Vice President, Corporate and Medical Affairs, Gilead Science, explained, “Gilead’s goal is to address the HIV epidemic across multiple fronts, including expanding worldwide access to antiretroviral treatment and supporting efforts to help prevent transmission of HIV among at-risk populations. Through this partnership with PEPFAR, we hope to provide adolescent girls and young women in sub-Saharan Africa, who traditionally have been disproportionately impacted by the epidemic, with an important tool that can help prevent them from acquiring HIV.

“Community organisations can play a vital role in delivering positive health outcomes in support of DREAMS,” said Dr. Dominique Limet, CEO, ViiV Healthcare. “For them, adolescent girls are not just a “target group”, but are their daughters, sisters, nieces, and neighbours.

Understanding their local needs best, they can develop initiatives that fit the local environment and challenge the practices that lead to the increased risk of HIV amongst adolescent girls.”

Leave a Reply

Your email address will not be published. Required fields are marked *